论文部分内容阅读
目的 :分析多索茶碱联合布地奈德治疗支气管哮喘的临床效果。方法 :采用随机数字表法选取我院2015年4月至2016年5月间收治的100例支气管哮喘患者作为研究对象,分为对照组及观察组,每组各50例。对照组行布地奈德治疗,观察组在对照组治疗基础上联合多索茶碱进行治疗,对两组患者的最终治疗结果进行观察和统计。结果 :观察组患者在治疗有效率、治疗满意度、肺通气指标方面明显优于对照组,两组对比具有明显差异,P<0.05,具有统计学意义。结论 :采用多索茶碱联合布地奈德治疗支气管哮喘能够较好缓解患者的临床症状,改善患者的肺通气指标,而且不良反应较小,能够较好维护患者健康,应用价值较高。
Objective: To analyze the clinical effect of doxofylline and budesonide in the treatment of bronchial asthma. Methods: A total of 100 patients with bronchial asthma admitted from April 2015 to May 2016 in our hospital were selected as random subjects. The patients were divided into control group and observation group, with 50 cases in each group. The control group treated with budesonide. The observation group was treated with doxofylline on the basis of the control group, and the final treatment results of both groups were observed and statistically analyzed. Results: The patients in the observation group were significantly better than the control group in the treatment efficiency, satisfaction with treatment, and lung ventilation index. There was significant difference between the two groups (P <0.05), with statistical significance. Conclusion: The use of doxofylline and budesonide in the treatment of bronchial asthma can better alleviate the clinical symptoms of patients and improve the patient’s pulmonary ventilation index, and adverse reactions are small, can better maintain the patient’s health, high value.